Anti-ADAMTS17 Aptamer SELEX Service(Cat#: CTApt-2392)

This is an aptamer development services to screening aptamers binds to the ADAMTS17 with an affinity of 1nM~1μM.

Datasheet MSDS COA
Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target ADAMTS17
Alternative Names ADAM Metallopeptidase With Thrombospondin Type 1 Motif 17; A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 17; A Disintegrin And Metalloproteinase With Thrombospondin Motifs 17; EC 3.4.24.82; EC 3.4.24.80; EC 3.4.24.- ; ADAM-TS 17; ADAM-TS17; ADAMTS-17; EC 3.4.24; ADAMTS17; FLJ32769; FLJ16363; WMS4
Gene ID 170691
UniProt ID Q8TE56
Target Overview This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry
×